Viltis Pharma Private Limited
About Viltis Pharma Private Limited
Data last updated:
Viltis Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U51909GJ2018PTC100924. Its GSTIN is 24AAGCV2930F1ZK (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shreyanssureshbhai Shah and Jinal Kirankumar Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.94 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹23.42 Lakh (net margin 12.1%) and EBITDA of ₹37.2 Lakh (EBITDA margin 19.2%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 24% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFirst Floor 121, Sukh Sagar Complex Nr Hotel Fortune Land Mark Usmanpura, Ahmedabad, Gujarat, India – 380013
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Viltis Pharma Private Limited FY 2025 filings available
Viltis Pharma Private Limited reported revenue of ₹1.94 Cr (up 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Viltis Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 24% over five years, including 15% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Viltis Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹37.2 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹23.42 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Viltis Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 12.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Viltis Pharma are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Viltis Pharma Private Limited
Viltis Pharma Private Limited is audited by MAMTA J SHAH & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MAMTA J SHAH & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Viltis Pharma Private Limited
Viltis Pharma has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shreyanssureshbhai Shah | Director | 14 Dec 2018 | 7 Years 9 Months | Current |
| Jinal Kirankumar Shah | Director | 21 Feb 2018 | 8 Years 7 Months | Current |
| Manojsingh Ramnath Rajput | Director | 23 Apr 2018 | 8 Years 5 Months | Current |
| Parita Shreyanskumar Shah | Director | 21 Feb 2018 | 8 Years 7 Months | Current |
Ownership and Shareholding of Viltis Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Viltis Pharma Private Limited
Viltis Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Viltis Pharma Private Limited
Employment history and EPFO contributions of people linked to Viltis Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Viltis Pharma Private Limited
Viltis Pharma Private Limited has 7 board changes on record since 2018: 4 appointments and 3 cessations. The latest: Manojsingh Ramnath Rajput ceased to be Additional Director on 30 Dec 2020.
Credit Ratings, Litigation & Regulatory Alerts for Viltis Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Viltis Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Viltis Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Viltis Pharma Private Limited
Viltis Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAGCV2930F1ZK | Gujarat | Active | 12 Apr 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Viltis Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Viltis Pharma Private Limited
Viltis Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 February 2018 (8+ years old) and is registered under CIN U51909GJ2018PTC100924.
Viltis Pharma reported revenue of ₹1.94 Cr for FY 2025 (up 15% YoY).
Viltis Pharma has 4 current directors:
- Shreyanssureshbhai Shah - Director
- Jinal Kirankumar Shah - Director
- Manojsingh Ramnath Rajput - Director
- Parita Shreyanskumar Shah - Director
Viltis Pharma reported a net profit of ₹23.42 Lakh (net margin 12.1%) and EBITDA of ₹37.2 Lakh (EBITDA margin 19.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Viltis Pharma is 20% over three years and 24% over five years. In the latest year (FY 2025) revenue rose 15%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Viltis Pharma is 24AAGCV2930F1ZK, registered in Gujarat.
The CIN (Corporate Identification Number) of Viltis Pharma is U51909GJ2018PTC100924. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Viltis Pharma was incorporated on 21 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Manojsingh Ramnath Rajput ceased to be Additional Director on 30 Dec 2020. Shreyanssureshbhai Shah ceased to be Additional Director on 30 Dec 2020. Shreyanssureshbhai Shah was appointed as Director on 14 Dec 2018. Viltis Pharma has 7 board changes on record in total.
The registered office of Viltis Pharma is at First Floor 121, Sukh Sagar Complex Nr Hotel Fortune Land Mark Usmanpura, Ahmedabad, Gujarat, India – 380013.